Abstract A 53 year old woman with symptomatic pacemaker associated superior vena cava syndrome was treated successfully with balloon angioplasty. She was well six months after the procedure.
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Case report A 53 year old woman presented with a long history of severe palpitation. Atrioventricular nodal reentrant tachycardia was confirmed at electrophysiological study. The arrhythmia was refractory to medical treatment (fig 1) . There was a gradient of 9 mmHg between the superior vena cava above the stenosis and the right atrium. The angiographic appearance was suggestive of a fibrotic stricture with no evidence of associated thrombus. Contrast injections into the cephalic vein in the left antecubital fossa showed another stenosis at the junction of the brachiocephalic and the subclavian veins on that side. Multiple collaterals were also present. Balloon angioplasty of the stenosis of the superior vena cava was undertaken. A 0 035 inch straight guide wire and 7F Gensini catheter were introduced from the right femoral vein and the wire was passed through the stenosis to the right subclavian vein. The catheter was then advanced through the stenosis to allow a 0035 inch exchange J guide to be introduced. The stenosis was then dilated with an 8 mm balloon catheter initially and then with a 10 mm balloon catheter (Mansfield). A good angiographic result was obtained (fig 2) Our patient is the first in whom balloon dilatation was used successfully as a primary treatment for stenosis of the superior vena cava: a stenosis of an innominate vein has been dilated and reported previously. 7 The stenosis that we dilated seemed to be fibrotic, and not associated with thrombus; it may have resulted from damage at the time of introduction of the pacing lead. The angioplasty technique we used was standard and no appreciable problems were encountered. We expect that any complications are likely to be those associated with vascular access, lead displacement, and caval rupture. Restenosis has been reported' but the likely incidence cannot be determined from the available reports.
Because the risk of cerebral haemorrhage is likely to be increased by the use of anticoagulants we recommend balloon angioplasty as the primary treatment for fibrotic strictures occurring in this unusual condition. Thrombolytic agents should be used only when coexistent thrombus is visible on angiography and they should be used with caution.
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